Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTX-3001 in Intractable Chronic Low Back Pain
NCT07122453Phase 1Recruiting
- Sponsor
- Centrexion Therapeutics
- Start
- Mar 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in low back pain (LBP) comparing CNTX-3001 with Placebo (2 arms). Primary endpoint: Incidence of treatment emergent adverse events at Day 7. Started Mar 2026; status: recruiting.
02
Drugs
CNTX-3001
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT07122453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07122453.